Oral azole drugs as systemic antifungal therapy.

@article{Como1994OralAD,
  title={Oral azole drugs as systemic antifungal therapy.},
  author={Jackson A Como and William E Dismukes},
  journal={The New England journal of medicine},
  year={1994},
  volume={330 4},
  pages={263-72}
}
The oral azole drugs--ketoconazole, fluconazole, and itraconazole--represent a major advance in systemic antifungal therapy. Among the three, fluconazole has the most attractive pharmacologic profile, including the capacity to produce high concentrations of active drug in cerebrospinal fluid and urine. Ketoconazole, the first oral azole to be introduced, is less well tolerated than either fluconazole or itraconazole and is associated with more clinically important toxic effects, including… CONTINUE READING

Citations

Publications citing this paper.
Showing 1-10 of 10 extracted citations

A Case of HIV-Associated Cerebral Histoplasmosis Successfully Treated with Fluconazole

European Journal of Clinical Microbiology and Infectious Diseases • 1999
View 12 Excerpts
Highly Influenced

Similar Papers

Loading similar papers…